康泰医学 (300869.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(康泰医学)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 122,747,980.38125,779,255.96368,699,882.77249,931,271.43130,053,431.63148,890,721.85183,239,114.02
 营业收入(元) 122,747,980.38125,779,255.96368,699,882.77249,931,271.43130,053,431.63148,890,721.85183,239,114.02
二、营业总成本(元) 117,496,849.96114,464,227.03197,193,260.98275,768,820.3271,846,697.37100,728,278.55103,354,061.98
 营业成本(元) 66,399,694.0159,539,166.74132,298,048.27124,254,428.9467,082,290.7782,669,194.94100,017,410.86
 研发费用(元) 28,308,265.4926,493,158.3225,005,015.8327,181,125.4224,798,289.3921,818,227.1319,456,247.08
 营业税金及附加(元) 2,034,711.222,018,115.806,922,175.644,996,105.642,928,101.371,251,644.23880,050.80
 销售费用(元) 17,594,442.3827,171,161.7334,329,659.1553,259,691.1412,152,220.4815,211,722.439,588,954.90
 管理费用(元) 9,631,385.988,342,456.7314,421,554.0614,227,416.816,347,145.036,193,940.507,666,532.33
 财务费用(元) -6,471,649.12-9,099,832.29-15,783,191.9751,850,052.33-41,461,349.63-26,416,450.69-34,255,133.98
 资产减值损失(元) -1,169,244.74-4,105,078.48-3,219,087.54-1,048,600.96-1,529,054.75-2,080,542.57-1,185,811.38
 信用减值损失(元) 624,762.98-373,611.6082,588.79-196,884.34-795,592.51-1,006,081.67-49,792.36
三、其他经营收益
 加:公允价值变动收益(元) 51,506.85-24,114,663.00-22,515,102.3738,083,650.30---
 加:投资收益(元) 1,034,333.3428,722,000.9927,350,274.44----
 其他收益(元) 3,896,907.4511,007,316.6914,999,764.194,900,846.091,493,829.243,100,997.102,920,431.26
四、营业利润(元) 9,689,396.3022,445,358.26188,205,059.3023,600,300.9865,928,716.2448,176,816.1681,569,879.56
 加:营业外收入(元) 303,775.3987,143.1941,356.68217,473.14262,916.812,474.63486.05
 减:营业外支出(元) 106,343.60188,571.93311,251.45130,894.9562,628.67135,010.4136,196.80
五、利润总额(元) 9,886,828.0922,343,929.52187,935,164.5323,686,879.1766,129,004.3848,044,280.3881,534,168.81
 减:所得税费用(元) -2,344,292.969,509,548.1617,883,112.511,690,708.287,298,998.845,975,885.208,226,181.89
六、净利润(元) 12,231,121.0512,834,381.36170,052,052.0221,996,170.8958,830,005.5442,068,395.1873,307,986.92
(一)按经营持续性分类
  持续经营净利润(元) --170,052,052.0221,996,170.89--73,307,986.92
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 12,231,121.0512,834,381.36170,052,052.0221,996,170.8958,830,005.5442,068,395.1873,307,986.92
 扣除非经常性损益后的净利润(元) 10,094,359.538,732,888.74164,074,230.91-27,117,617.9858,501,442.6140,750,333.7072,554,455.59
七、每股收益
 一、基本每股收益(元) 0.030.040.420.060.140.110.18
 二、稀释每股收益(元) -0.040.420.05---
八、其他综合收益(元) -293,793.462,185,554.73-559,565.39-745,671.972,088,291.512,483,666.19-833,643.81
 归属于母公司股东的其他综合收益(元) -293,793.462,185,554.73-559,565.39-745,671.972,088,291.512,483,666.19-833,643.81
九、综合收益总额(元) 11,937,327.5915,019,936.09169,492,486.6321,250,498.9260,918,297.0544,552,061.3772,474,343.11
 归属于母公司所有者的综合收益总额(元) 11,937,327.5915,019,936.09169,492,486.6321,250,498.9260,918,297.0544,552,061.3772,474,343.11
公告日期 2023-10-302023-08-302023-04-272023-04-272022-10-272022-08-272022-04-29
审计意见(境内) 标准无保留意见

前瞻产业研究院